Skip to main content
In stock | Targeted Therapy (Investigational)

Devimistat

Oncology Type Solid Tumour
Drug Class / Mechanism Metabolic Pathway Inhibitor (IDO/STAT3/Glutaminase)
No Image
Description

Devimistat is classified as a Metabolic Pathway Inhibitor (IDO/STAT3/Glutaminase), sourced for use within our Targeted Therapy (Investigational) portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic Category Targeted Therapy (Investigational)
Oncology Type Solid Tumour

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3